Product Information

POTASSIUM CL ER 8 MEQ CAPSULE is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.1045 per EA under NDC 70010014701. Its NADAC has been published 257 times since Dec 15, 2021.

FDA first approved this application on Feb 16, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 8 MEQ CAPSULE

Potassium Chloride
$0.1045per EA

Strength

600 mg/1

NDC

70010014701

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA214686

FDA Approved

2/16/2021

TE Code

AB

On Market Since

3/1/2021

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has been published 257 times since Dec 15, 2021, and over the history we have for it it has declined 56.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1045 per EA
All-time high$0.2404 (Dec 15, 2021)
All-time low$0.0914 (Jul 22, 2026)
52-week high$0.1264
52-week low$0.0914
Median price$0.1432
Average price$0.1451
Largest weekly change-44.0% (Nov 23, 2022)
Weeks tracked257
Tracking sinceDec 15, 2021

Price History

1W

0.0%

1M

+4.7%

3M

+14.3%

6M

-12.6%

1Y

-18.3%

3Y

-22.0%

5Y

N/A

All

-56.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 2%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 8 MEQ CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ CAPSULE, manufactured by Granules Pharmaceuticals Inc., is $0.1045 per EA (NDC 70010014701), effective Nov 11, 2026.

How has the price of POTASSIUM CL ER 8 MEQ CAPSULE changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has declined 56.5%. It has been tracked across 257 weekly CMS publications since Dec 15, 2021.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ CAPSULE?

Since Dec 15, 2021, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has ranged from a low of $0.0914 (Jul 22, 2026) to a high of $0.2404 (Dec 15, 2021), with a median of $0.1432 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ CAPSULE?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 8 MEQ CAPSULE, is $0.1025 per EA — about 2% below POTASSIUM CL ER 8 MEQ CAPSULE.

Who manufactures POTASSIUM CL ER 8 MEQ CAPSULE?

POTASSIUM CL ER 8 MEQ CAPSULE (NDC 70010014701) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.